CAPTRUST Financial Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$263K Buy
74,930
+11,108
+17% +$45.5K ﹤0.01% 2478
2025
Q4
$215K Buy
63,822
+668
+1% +$1.74K ﹤0.01% 2480
2025
Q3
$82.7K Buy
63,154
+18,707
+42% +$19.4K ﹤0.01% 2529
2025
Q2
$31.9K Buy
+44,447
New +$34.9K ﹤0.01% 2459
2025
Q1
Sell
-26,894
Closed -$119K 2407
2024
Q4
$119K Buy
26,894
+153
+0.6% +$621 ﹤0.01% 2192
2024
Q3
$110K Sell
26,741
-877
-3% -$4.71K ﹤0.01% 2197
2024
Q2
$180K Buy
27,618
+868
+3% +$6.14K ﹤0.01% 2064
2024
Q1
$233K Sell
26,750
-3,013
-10% -$36.6K ﹤0.01% 1919
2023
Q4
$340K Buy
+29,763
New +$294K ﹤0.01% 2019
2022
Q3
Sell
-6,690
Closed -$77K 3048
2022
Q2
$77K Buy
6,690
+5,455
+442% +$64.3K ﹤0.01% 2414
2022
Q1
$16K Buy
1,235
+142
+13% +$1.63K ﹤0.01% 3530
2021
Q4
$13K Buy
1,093
+394
+56% +$4.83K ﹤0.01% 3563
2021
Q3
$9K Sell
699
-53
-7% -$685 ﹤0.01% 3669
2021
Q2
$10K Sell
752
-2,970
-80% -$34K ﹤0.01% 3542
2021
Q1
$42K Buy
3,722
+3,670
+7,058% +$38.8K ﹤0.01% 2543
2020
Q4
$1K Buy
+52
New +$569 ﹤0.01% 3262

Other funds holding IRWD

CAPTRUST Financial Advisors's IRWD Position: Q1 2026 in Review

CAPTRUST Financial Advisors increased its Ironwood Pharmaceuticals (IRWD) stake by 17% in Q1 2026, buying an estimated $45.5K and bringing the position to 74,930 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #2478.

CAPTRUST Financial Advisors first reported a position in IRWD in Q4 2020 and has held it in 16 quarters since. The position peaked at $340K in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • CAPTRUST Financial Advisors held 74,930 shares of Ironwood Pharmaceuticals worth $263K as of Q1 2026.
  • CAPTRUST Financial Advisors bought 11,108 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $45.5K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2478 holding.
  • CAPTRUST Financial Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2020 and has held it in 16 quarters since.
  • CAPTRUST Financial Advisors's Ironwood Pharmaceuticals position peaked at $340K in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.